Last reviewed · How we verify
NCT03713970
Clinical Performance of Ceramic Laminate Veneers Made With Celtra Duo Press and IPS e.Max Press Ceramic
NA trial testing celtra duo press in Fracture in 6 participants. Completed in 1 August 2022.
1 July 2022
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 25 August 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 August 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- celtra duo press
- IPS e.max press
Conditions studied
- Fracture — all drugs for Fracture →
- Tooth Discoloration — all drugs for Tooth Discoloration →
Sponsor
Cairo University
Who can join
Adults 18 to 60, any sex, with Fracture or Tooth Discoloration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to assess the clinical performance (patient satisfaction, fracture, shade matching, Marginal adaptation and sensitivity) of laminate veneers made with celtra duo press ceramic and IPS e.max press ceramic with incisal wrap design.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03713970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fracture
Currently open trials in the same condition.
- NCT07221019 — Single Shot Exparel vs Catheters in Lower Extremity Trauma · Phase 4 · recruiting
- NCT04921865 — Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems · recruiting
- NCT04947722 — The PREVENT Trial: a Pragmatic Cluster Randomized Controlled Trial of a Multifaceted Fracture Prevention Model for Long- · NA · recruiting
- NCT07256405 — Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection · active not recruiting
- NCT05292001 — Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma · Phase 4 · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03713970 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 12 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03713970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing